Last reviewed · How we verify
0.3% benzydamine hydrochloride spray oromucosal solution — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
0.3% benzydamine hydrochloride spray oromucosal solution (0.3% benzydamine hydrochloride spray oromucosal solution) — Aziende Chimiche Riunite Angelini Francesco S.p.A.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| 0.3% benzydamine hydrochloride spray oromucosal solution TARGET | 0.3% benzydamine hydrochloride spray oromucosal solution | Aziende Chimiche Riunite Angelini Francesco S.p.A | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- 0.3% benzydamine hydrochloride spray oromucosal solution CI watch — RSS
- 0.3% benzydamine hydrochloride spray oromucosal solution CI watch — Atom
- 0.3% benzydamine hydrochloride spray oromucosal solution CI watch — JSON
- 0.3% benzydamine hydrochloride spray oromucosal solution alone — RSS
Cite this brief
Drug Landscape (2026). 0.3% benzydamine hydrochloride spray oromucosal solution — Competitive Intelligence Brief. https://druglandscape.com/ci/0-3-benzydamine-hydrochloride-spray-oromucosal-solution. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab